Indivior Inc To Pay $10 Million After Settling FTC Charges It Used Anticompetitive Tactics To Impede Competition From Lower-Cost Suboxone Generics
This week, Indivior Inc. agreed to pay $10 million to settle Federal Trade Commission charges that it had violated antitrust...